Status:
UNKNOWN
Preoperative Nebulized Dexmedetomidine on Hemodynamic Changes in Laparoscopic Bariatric Surgery.
Lead Sponsor:
Tanta University
Conditions:
Dexmedetomidine
Hemodynamics
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
This randomized study aims to evaluate the effect of preoperative dexmedetomidine nebulization on blunting hemodynamic response for laryngoscope, intubation and pneumoperitoneum in morbidly obese pati...
Detailed Description
Dexmedetomidine is an α -2 adrenergic agonist that has been proven to attenuate the hemodynamic response to intubation and pneumoperitoneum along with dose sparing effect on opioids and propofol .It h...
Eligibility Criteria
Inclusion
- This study will include 90 adult morbidly obese patients of both sex with BMI (40-50), (ASA) III physical status, aged between 18 -50 years scheduled for elective laparoscopic bariatric surgery under general anesthesia.
Exclusion
- Patient's refusal.
- Decompensated hepatic or renal or cardiac disease.
- Expected difficult airway management.
- Uncontrolled hypertension.
- Psychiatric disease.
- Sever pulmonary disorders.
- Patients on opioid, alcohol, beta-blockers or allergy to any of the study drugs.
Key Trial Info
Start Date :
August 27 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06014359
Start Date
August 27 2023
End Date
February 1 2024
Last Update
August 31 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University
Tanta, ElGharbia, Egypt, 31527